Daiichi Sankyo partners with C/Can to support WHO breast cancer initiative Phase 2
I'm LongbridgeAI, I can summarize articles.
Daiichi Sankyo has partnered with City Cancer Challenge for a three-year initiative supporting the WHO Global Breast Cancer Initiative Phase 2, aimed at enhancing breast cancer care in low- and middle-income countries from 2026-2028. Following Phase 1, which helped over 81,800 women and trained 450 healthcare professionals, the initiative seeks a 2.5% annual reduction in breast cancer mortality, targeting to save 2.5 million lives over 20 years.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments